ICMR - National Institute for Research
in Bacterial Infections
आईसीएमआर - राष्ट्रीय जीवाणु संक्रमण अनुसंधान संस्थान
Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार
WHO Collaborating Centre For Research and Training On Diarrhoeal Diseases
NICED : Scientists
Dr. Rituparna De
General Information
| Name | Dr. Rituparna De |
|---|---|
| Designation | DHR NRI (Scientist C ) |
| Educational Qualification | Msc, PhD |
| Date of Joining ICMR | 11th July,2018 |
| Date of Joining Present Post | |
| Discipline | Molecular Epidemiology, Microbiology, Metagenomics |
| Division | |
| Email : | |
| Academic Qualifications | |
| Graduation | |
| Post Graduation |
Profile
Dr. Rituparna De joined ICMR-NIRBI as DHR NRI (Scientist C
and PI) in 2018 on being awarded the DHR NRI grant by the
Department of Health
Research, MoHFW, GoI and is heading her research in Metagenomics and AMR. She has 19 years of research experience in the field of Molecular Epidemiology of Infectious Diseases and chronic Diseases. She is a doctoral alumna of NIRBI (then NICED) and was guided for PhD on the Molecular Epidemiology of Vibrio cholerae by Dr. G.B. Nair. She has carried out her postdoctoral research at the Ohio State University, USA and Umea University, Sweden from 2012-2018 and worked on miRNAs in cancer, MRSA AMR, Celiac Disease microbiome and PDAC microbiome research. She has previously worked as Microbiologist under WHO at the National Polio Laboratory. Dr. De has obtained short-term pre- and postdoctoral training at ICDDR,B, Dhaka, Karolinska Institute, Sweden and was selected as visiting researcher and collaborator at the European Bioinformatics Institute
(EMBL-EBI), Cambridge, UK in 2019.
Her research contributions include the identification of the first WPV 3 strain during the resurgence in 2007 in Kolkata, the circulation of the Haitian Vibrio cholerae genotype in 2007-2008 after their discovery by Kumar et al., the carriage of Vibrio cholerae in non-cholera diarrheal stool, characterization of the diarrheal microbiome, identification and characterization of probiotic strains and was the first to identify the key transcriptional factor responsible for the chronic inflammation in Celiac Disease and the role of the microbiome as the epigenetic regulator. She was the first to use Human Organoids in CD which changed the landscape of CD research. She was selected as Top 20 Young Investigators at the 14th Probiotic Symposium, Trivandrum, India, by the Gut Microbiota and Probiotic Science Foundation, India. She was nominated as member of the Expert Group of ICMR’s Gut Microbiome Initiative in 2024. She has multiple publications in esteemed journals, book chapters and served as guest editor. Her research interests are in microbial evolution and ecology.
Research, MoHFW, GoI and is heading her research in Metagenomics and AMR. She has 19 years of research experience in the field of Molecular Epidemiology of Infectious Diseases and chronic Diseases. She is a doctoral alumna of NIRBI (then NICED) and was guided for PhD on the Molecular Epidemiology of Vibrio cholerae by Dr. G.B. Nair. She has carried out her postdoctoral research at the Ohio State University, USA and Umea University, Sweden from 2012-2018 and worked on miRNAs in cancer, MRSA AMR, Celiac Disease microbiome and PDAC microbiome research. She has previously worked as Microbiologist under WHO at the National Polio Laboratory. Dr. De has obtained short-term pre- and postdoctoral training at ICDDR,B, Dhaka, Karolinska Institute, Sweden and was selected as visiting researcher and collaborator at the European Bioinformatics Institute
(EMBL-EBI), Cambridge, UK in 2019.
Her research contributions include the identification of the first WPV 3 strain during the resurgence in 2007 in Kolkata, the circulation of the Haitian Vibrio cholerae genotype in 2007-2008 after their discovery by Kumar et al., the carriage of Vibrio cholerae in non-cholera diarrheal stool, characterization of the diarrheal microbiome, identification and characterization of probiotic strains and was the first to identify the key transcriptional factor responsible for the chronic inflammation in Celiac Disease and the role of the microbiome as the epigenetic regulator. She was the first to use Human Organoids in CD which changed the landscape of CD research. She was selected as Top 20 Young Investigators at the 14th Probiotic Symposium, Trivandrum, India, by the Gut Microbiota and Probiotic Science Foundation, India. She was nominated as member of the Expert Group of ICMR’s Gut Microbiome Initiative in 2024. She has multiple publications in esteemed journals, book chapters and served as guest editor. Her research interests are in microbial evolution and ecology.